Retagliptin
Pou rechèch syantifik sèlman, pa pou pasyan yo.
Pwodwi detay
Tags pwodwi
Gwosè pake | Disponibilite | Pri (USD) |
Non Chimik:
(R)-methyl 7-(3-amino-4-(2,4,5-trifluorophenyl)butanoyl)-3-(trifluorometil)-5,6,7,8-tetrahydroimidazo[1,5-a]pirazin- 1-carboxylate fosfat
Kòd SMILES:
COC(C1=NC([N]2=C1CN(C(C[C@@H](CC3=C(F))C=C(F)C(F)=C3)N)=O)CC2)C (F)(F)F)=O
Kòd InChi:
InChI=1S/C19H19F6N4O3/c1-32-17(31)16-14-8-28(2-3-29(14)18(27-16)19(23,24)25)15(30)6- 10(26)4-9-5-12(21)13(22)7-11(9)20/h5,7,10,18H,2-4,6,8,26H2,1H3/t10-,18 ?/m1/s1
InChi kle:
FXBCTRLEFVUDDC-DMPGVRBJSA-N
Mot:
Retagliptin, SP-2086,SP2086,1174122-54-3, 1256756-88-3
Solibilite:Soluble nan DMSO
Depo:0 - 4 ° C pou kout tèm (jou a semèn), oswa -20 ° C pou tèm long (mwa).
Deskripsyon:
Retagliptin, ke yo rele tou SP-2086, se yon inibitè DPP-4 ki kapab itilize pou tretman dyabèt tip 2.
Sib: DPP-4